Participation of animal biotransformation in mycotoxin toxicity

Revue de Medecine Veterinaire

Volumn 149, Issue 6, 1998, Pages 555-560

  Neal, G E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Aflatoxins; Bioactivation; Biotransformation; Metabolism; Ochratoxins; Toxicity

Indexed keywords

EID: 0000233044     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. BAUDRIMONT I., BETBEDER A.M., GHARBI A., PFOHL-LESZ-KOWICZ A., DIRHEIMER G. and CREPPY E.E. : Effect of superoxide dismutase and catalase on the nephrotoxicity induced by the sub-chronic administration of ochratoxin A in rats. Toxicol., 1994, 89, 101-111.
2. 14C-labelled fumonisin B mycotoxins with primary rat hepatocyte cultures. Food Chem. To-xicol., 1994, 32, 627-632.
3. CREPPY E.E., BAUDRIMONT I. and BETBEDER A.M. : Prevention of nephrotoxicity of ochratoxin A, a food contaminant. Toxicol Letters, 1995, 83, 869-877.
4. DE GROENE E.M., HASSING I.G.A.M., BLOM. M.J., SEINEN W. FINK GREMMELS J. and HORBACH G. J. : Development of human cytochrome P450-expressing cell lines: application in mutatgenicity testing of ochratoxin. A. Cancer Res., 1996, 56, 299-304.
5. 1 in human lung. Carcinogenesis, 1996, 17, 2487-2494.
6. FITZPATRICK D.W., PICKEN C.A. MURPHY L.C. and BUHR M.M. : Measurement of the relative binding affinity of zearalenone and -zearalenol and β-zearalenol for uterine and oviduct estrogen receptors in swine, rats and chickens : an indicator of estrogenic potencies. Comp. Biochem. Physiol., 1989, 94C, 691-694.
7. FORRESTER L.M., NEAL G.E., JUDAH D.J., GLANCEY M.J. and WOLF C.R. : Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin metabolism in human liver. Proc. Nail. Acad. Sci. U.S.A., 1990, 87, 8306-8310.
8. 1. Cancer Res., 1994, 54, 101-108.
9. 1-8.9-epoxide. Biochem . J., 1991, 279, 385-398.
10. 1. Pharmac. Ther., 1991, 50, 443-472.
11. 1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant. Biochem. J., 1993, 292, 13-18.
12. KOLLARCZIK B., GAREIS M. and HANELT M. : In vitro transformation of the fusarium mycotoxins, deoxynivalenol and zearalenone by the normal gut microflora of pigs. Natural Toxins., 1994, 2, 105-110.
13. KROGH P. : Role of ochratoxin in disease causation. Fd. Chem. Toxicol, 1992, 30, 213-224.
14. MALAVEILLE C., BRUN G. and BARTSCH H. : Genotoxicity of ochratoxin A and structurally-related compounds in E. coli strains: studies on their mode of action. In : M. CASTEGNARO, R. PLESTINA, G. DIRHEIMER, I.N. CHERNOZEM-SKY and H. BARTSCH. (Eds) Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours I.A.R.C. Publications. No 115, 1991, p 261-266.
15. OMER R.F., GELBOIN H.V. and RAHIMTULA A.D. : Effect of cytochrome P450 induction on the metabolism and toxicity of ochratoxin. A. Biochem. Pharmacol., 1996, 51, 207-216.
16. PFOHL-LESZKOWICZ A., GROSSE Y., KANE A., CREPPY E.E. and DIRHEIMER G. : Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin ochratoxin A. Mutation Res., 1993, 289, 265-273.
17. 1 exo and endo-epoxides by rat and human glutathione S-transferases. Chem. Res. Toxicol., 1992, 5, 470-478.
18. REUBEL G.H., GAREIS M. and AMSELGRUBER W.M. : Effects of the fusarium mycotoxins zearalenone and deoxynivalenol on the mitochondrial MTT cleavage activity of monolayer cells. Toxicol. In vitro. 1989, 3, 311-316.
19. 1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity. Journal of Nutrition, 1994., 124, 594-603.
20. RILEY R.T., WANG E. and MERRILL A.H. : Liquid Chromatographic determination of sphinganine and sphingosine : use of free sphinganine to sphingosine ratio as a biomarker for consumption of fumonisins. Journal Association of Official Analytical Chemists international, 1994, 77, 533-540.
21. 1 by bacterial recombinant human cytochrome P450 enzymes. Chemical Res. Toxicol, 1995, 8, 218-225.